A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults
Motivate Vaccinate Activate: An Effectiveness-Implementation Trial to Assess the Impact of a Multi-Component Community-Based Intervention to Increase RSV Vaccine Uptake Among Latino Older Adults
2 other identifiers
interventional
750
1 country
1
Brief Summary
In collaboration with community-based organizations, this study will focus on increasing RSV vaccine use among Latinos. The study will determine how effective community health worker counseling and text-message approaches are to (1) increase RSV vaccine use among older adults (Motivate phase) and (2) encourage younger adults to discuss RSV vaccination with their older friends and family members (Activate phase).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2025
CompletedStudy Start
First participant enrolled
September 10, 2025
CompletedFirst Posted
Study publicly available on registry
September 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2028
September 30, 2025
September 1, 2025
3.1 years
September 5, 2025
September 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Motivate Aim Primary Outcome - RSV Vaccine Uptake
RSV vaccine uptake at 60 days per California Immunization Registry (CAIR) or per medical record
60 days from study enrollment
Activate Aim Primary Outcome - Proportion of Contacts with whom RSV Vaccination Discussed
Self-reported average proportion of social network contacts 50 years or older with whom participant discussed RSV vaccination at 60 days
60 days after study enrollment
Study Arms (4)
Motivate Aim: CHW text message reminders and counseling
EXPERIMENTALMotivate Aim: CHW text message reminders only
ACTIVE COMPARATORActivate Aim: CHW text message reminders and counseling
EXPERIMENTALActivate Aim: CHW text message reminders only
ACTIVE COMPARATORInterventions
Participants receive both text message reminders and a counseling session, along with information about RSV and the vaccine, to encourage RSV vaccine uptake.
Participants receive text message reminders along with information about RSV and the RSV vaccine to encourage vaccine uptake, but do not receive the counseling intervention
Participants receive both text message reminders and a counseling session, along with information about RSV and the vaccine, to encourage discussion of RSV vaccine uptake among older adults in their social networks
Participants receive text message reminders along with information about RSV and the vaccine to encourage discussion of RSV vaccine uptake among older adults in their social networks, but do not receive the counseling intervention
Eligibility Criteria
You may qualify if:
- Age 50 years or older
- Self-identify as Latino/a/x and/or indigenous groups from Latin America
- Eligible for RSV vaccination per current CDC/ACIP recommendations
- Fluent in Spanish or English
- Has not received the RSV vaccine
- Has a cell phone
- Lives or works in San Francisco or Daly City
- Able to provide informed consent
You may not qualify if:
- Intent to move outside of San Francisco or Daly City in the next year
- Nursing home resident
- Household member participating in Aim 1 or 2
- Unable to provide consent
- Age 18-49 years
- Self-identify as Latino/a/x and/or indigenous groups from Latin America
- Fluent in English or Spanish
- Has \>1 family member or friend 50 years or older who they have seen or spoken to for \>15 minutes in the last 6 months and who lives in the United States
- Household member enrolled in Aim 1 or 2
- Unable to provide consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, San Francisco
San Francisco, California, 94110, United States
Related Publications (5)
Ackerson B, Tseng HF, Sy LS, Solano Z, Slezak J, Luo Y, Fischetti CA, Shinde V. Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults. Clin Infect Dis. 2019 Jul 2;69(2):197-203. doi: 10.1093/cid/ciy991.
PMID: 30452608BACKGROUNDJuhn YJ, Wi CI, Takahashi PY, Ryu E, King KS, Hickman JA, Yao JD, Binnicker MJ, Natoli TL, Evans TK, Sampathkumar P, Patten C, Luyts D, Pircon JY, Damaso S, Pignolo RJ. Incidence of Respiratory Syncytial Virus Infection in Older Adults Before and During the COVID-19 Pandemic. JAMA Netw Open. 2023 Jan 3;6(1):e2250634. doi: 10.1001/jamanetworkopen.2022.50634.
PMID: 36662530BACKGROUNDZheng Z, Warren JL, Shapiro ED, Pitzer VE, Weinberger DM. Estimated incidence of respiratory hospitalizations attributable to RSV infections across age and socioeconomic groups. Pneumonia (Nathan). 2022 Oct 25;14(1):6. doi: 10.1186/s41479-022-00098-x.
PMID: 36280891BACKGROUNDMahmud SM, Xu L, Hall LL, Puckrein G, Thommes E, Loiacono MM, Chit A. Effect of race and ethnicity on influenza vaccine uptake among older US Medicare beneficiaries: a record-linkage cohort study. Lancet Healthy Longev. 2021 Mar;2(3):e143-e153. doi: 10.1016/S2666-7568(20)30074-X. Epub 2021 Feb 18.
PMID: 36098112BACKGROUNDMcLaughlin JM, Khan F, Begier E, Swerdlow DL, Jodar L, Falsey AR. Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis. Open Forum Infect Dis. 2022 Jun 17;9(7):ofac300. doi: 10.1093/ofid/ofac300. eCollection 2022 Jul.
PMID: 35873302BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carina Marquez, MD
University of California, San Francisco
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2025
First Posted
September 12, 2025
Study Start
September 10, 2025
Primary Completion (Estimated)
November 1, 2028
Study Completion (Estimated)
November 1, 2028
Last Updated
September 30, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share